Jul 30, 09:11
Jul 30, 09:07
Only BuyersOnly Buyers in Ind-Swift Labs on NSE
100% of moneycontrol users recommend buying Ind-Swift Labs.
What's your call on Ind-Swift Labs today?
Read 4 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2777.15||0.38||2939.80||2140.35||47,304.60|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Sical Logistics Recommended on Jun 2nd 2014
Recommended price 85.00 | Peak from reco 129.40 53.14%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ind-Swift Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 183.72 crore.The company has reported a standalone sales of Rs 209.90 crore and a Net Loss of Rs -64.52 crore for the quarter ended Mar 2014.
The company management includes S R Mehta - Chairman, N R Munjal - Vice Chairman & Mng.Director, Himanshu Jain - Joint Managing Director, Rishav Mehta - Executive Director, V R Mehta - Director, G Munjal - Director, K M S Nambiar - Director, T S Bhattacharya - Director, J K Kakkar - Director, Pradeep Kumar - Director, Satyendra Vikram Singh - Nominee Director, Vinay Kumar Arora - Independent Director.
It is listed on the BSE with a BSE Code of 532305 and the NSE with an NSE Code of INDSWFTLAB.
Its Registered office is at SCO 850, Shivalik Enclave,,NAC, Manimajra Chandigarh,Chandigarh - 160101.
Their Registrars are Alankit Assignment Ltd.